Related Experiment Video
Updated: Jul 17, 2026
06:50
A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
Immunomodulatory therapy in yeast infections
Jorge Garbino1, Aspasia Katragkou, Emmanuel Roilides
1University Hospitals of Geneva, Infectious Diseases Division (Clinical Research), 24 Rue Micheli du Crest, 1211 Geneva 14, Switzerland. jorge.garbino@hcuge.ch
Expert Review of Anti-Infective Therapy
|February 3, 2007
Summary
Invasive yeast infections pose a serious threat to immunocompromised patients. Restoring immune function, rather than just using antifungals, is key to resolving these dangerous infections.
Area of Science:
- Medical Mycology
- Immunology
- Infectious Diseases
Background:
- Invasive yeast infections cause significant illness and death in vulnerable populations, including cancer patients, transplant recipients, and neonates.
- Intensive care unit (ICU) stays and the rise of drug-resistant fungal strains exacerbate this growing public health concern.
- Despite advances in antifungal therapies, increasing numbers of susceptible individuals and emerging resistant strains present escalating challenges.
Purpose of the Study:
- To explore the role of host immune response in resolving invasive yeast infections.
- To review current and emerging strategies for managing yeast infections in at-risk populations.
- To highlight the importance of immunomodulation in combating invasive fungal diseases.
Main Methods:
- Review of recent advances in immunology and molecular biology related to yeast infection pathogenesis.
- Analysis of evidence supporting immune reconstitution strategies.
- Synthesis of findings from preclinical and clinical studies on immunomodulatory therapies.
Main Results:
- Host immune function reconstitution is a critical factor in overcoming yeast infections.
- Strategies like increasing phagocyte counts, immune stimulation (cytokines, growth factors), and antigen-specific immunity (antibodies, vaccines) show promise.
- These immunomodulatory approaches offer benefits for patients at risk or suffering from invasive yeast infections.
Conclusions:
- Understanding immune system function and dysfunction is crucial for developing effective treatments.
- Future research should focus on further preclinical and clinical studies to refine immunotherapeutic strategies.
- A comprehensive approach combining antifungal agents with immune-based therapies is essential for managing invasive yeast infections.
Related Concept Videos
01:28Yeast Signaling
Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...